Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer. (Q40480063)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer. |
scientific article |
Statements
1 reference
Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer. (English)
1 reference
Johann de Bono
1 reference
Anthony W Tolcher
1 reference
Desiree Hao
1 reference
Alex Miller
1 reference
Amita Patnaik
1 reference
Lisa A Hammond
1 reference
Leslie Smetzer
1 reference
Jill Van Wart Hood
1 reference
James Merritt
1 reference
Eric K Rowinsky
1 reference
Chris Takimoto
1 reference
Dan Von Hoff
1 reference
S Gail Eckhardt
1 reference
1 May 2006
1 reference
1 reference
24
1 reference
13
1 reference
2052-2058
1 reference
Identifiers
1 reference
1 reference